Objective To determine the accuracy with which parents can estimate preschool children's weight using home scales in order to calculate antipyretic dose. Design Cross-sectional, method comparison study. Setting and participants 156 preschool children aged 6 months to 6 years recruited from primary care and the community to an antipyretic strategies trial and managed at home. Comparison and outcome measures Research nurse weight estimate using Seca 835-2 digital paediatric scales compared with parental weight estimate using usual home scales. Results Parents of 62 (40%) preschool children had home scales. Research scale estimated weights were heavier than home scale weight estimates, with a mean difference of 0.41 kg (95% CI −0.24 to 0.74 kg), with 95% limits of agreement of −2.44 to 1.47 kg. Conclusion Weight can be estimated accurately enough to calculate antipyretic medicine doses by the minority of parents having scales that can be used to estimate their child's weight.
INTRODUCTION
Medicine dose calculation can be based on a child's age, weight or surface area. 'Dosing by age' is typically used by UK parents because the quantities are listed on the medicine packaging and the method is easy to use. 1 Unlike some European and US antipyretic products, UK products do not contain dose by weight guidance for parents, although in common with all paediatric formularies, the British National Formulary for Children (BNFC) presents doses per kilogram. 2 The UK National Service Framework for Children, young people and maternity services 1 states that children should receive age-, weight-and development-appropriate medicines. Moreover, in order to reduce medication error and improve dosing, it recommends that prescribing should be by weight, that is, in mg/kg. Prodigy has also issued guidance stating that antipyretics should be dosed by weight (paracetamol 15 mg/ kg up to four times daily and ibuprofen 10 mg/kg up to three times daily). 3 13 Studies have shown that parents generally underdose children when administering antipyretic medicine. A US study investigating paracetamol and ibuprofen dosing by parents found that 51% of patients received an inaccurate dose of medication, but that caregivers who stated that medication dosage was based on weight were less likely to give an inaccurate dose. 4 To our knowledge, although infant-related factors infl uencing the actual weight measured are known, no previous studies have investigated if parents can use home scales to accurately weigh children to determine appropriate antipyretic medicine dose.
METHODS
This study aimed to investigate if parents could accurately estimate preschool children's weight using ordinary home scales in order to calculate antipyretic doses.
The PITCH (Paracetamol plus Ibuprofen for the Treatment of Fever in Children) study, a randomised trial designed to establish the effectiveness of paracetamol, ibuprofen or a combination of both in treating fever in preschool children, 5 used two methods for determining child's weight: a research nurse measured weight using digital paediatric scales and, if a scale was available, a parent measured weight using home scales. We estimated the level of agreement between the two methods of measurement, as a means of assessing if parents could accurately weigh their children and hence dose by weight.
Children were recruited to the PITCH trial according to a protocol previously described. 6 Briefl y, preschool children were included if aged between 6 months and 6 years and unwell with a temperature of at least 37.8°C and up to 41°C due to illnesses that could be managed at home.
Children were randomised to receive either: (1) paracetamol active and ibuprofen active ; (2) paracetamol active and ibuprofen placebo ; or (3) paracetamol placebo and ibuprofen active . The dose of medicine was determined by the child's weight. 7 Once consent was obtained, the child was undressed to one layer, without nappy or shoes, and weighed on a Seca 835-2 baby and teenager scale (Seca, Hamburg, Germany). Weight was recorded to the nearest 100g. The Seca 835-2 weighing scales were regularly calibrated throughout the study period. If the parent had a home weighing scales, the details were noted on the case report form and the child's weight was measured on the home scales by the parent. The weight measurements were then entered into the equations given in box 1 to produce a volume of antipyretic to be administered to the child. For 
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the purposes of the study dosing, the Seca measurement was used to determine actual doses given.
For example, a child weighing 10 kg would receive a dose of 6.25 ml paracetamol up to four times daily, and a dose of 5 ml of ibuprofen up to three times daily.
All data were analysed using Stata 11. 8 First, two graphical methods were used to examine agreement. Dose was calculated using both weight measurements. Graphs were also produced representing the maximum daily doses that could be administered according to age, compared with the maximum daily dose that could be administered according to weight in 2, 50 and 98 percentiles of childhood weight. 2 Home scale weight was plotted against paediatric scale weight, then the difference between the measurements for each subject was plotted against the mean. 9 The Pitman's permutation test was used to test the difference in variance for paired data. 10 11 The difference between home scale weight measurement and paediatric nurse weight measurement was calculated for each child and a mean difference and SD of the differences recorded. 95% limits of agreement were calculated for the mean. Weight observations that were outside the limits of agreement were investigated for their potential effect on overdosing a child. The study was approved by the Bath Research Ethics Committee, UK (reference number 04/Q2001/197).
RESULTS
The parents of 62 (40%) children had scales present in the home and most (56%) scales were analogue. There were no differences between preschool children whose parents had scales at home and those who did not in terms of age, gender, comorbidities, weight or fever severity (table 1) . Parents who did not have a home scales had a higher deprivation score than parents who had a home scales (p<0.05).
The mean difference in (nurse minus parent measured) weight was +0.48 kg (95% CI +0.24 to +0.73 kg). The 95% limits of agreement defi ning the range within which most of the differences fell was 1.47 to −2.44 kg (table 2). 9 The BlandAltman plots shows that the difference between nurse and parent measured weight remained relatively constant with varying child weights (fi gure 1). Intermeasurement agreement analysis showed that there was no evidence of any difference between the two measurements (p=0.39).
According to BNFC guidelines and using the doses calculated, a child would be given too much medicine if their weight was over-estimated by 2 kg. The Bland-Altman plot indicates that this was the case for one child, whose parent measured weight was greater than the nurse measured weight by 4 kg. Figure 2 compares the different total medicine doses for paracetamol and ibuprofen if calculated by weight (given two extreme and one central weight percentile) and age. The stepped dose that age calculations produce and the differences in total daily doses that are produced between weight and age calculations are shown.
There was strong evidence that the dosing according to weight resulted in a higher dose of ibuprofen than if the child had received a daily dose calculated using their age, with a mean difference of +127.1 mg (95% CI +100.0 to +154.2 mg, p<0.001). Using parent measured weight to calculate a daily paracetamol dose resulted in children receiving a lower dose than if age was used, with a mean difference of −74.3 mg (95% CI −89.5 to −29.0 mg, p<0.001).
DISCUSSION
The results show that there is good agreement between the two methods of weight measurement. Within the dose by age regimen, there are some large dose differences across certain age categories. The difference in the dose of paracetamol is also large for heavier 3 and 4 year olds, who would be underdosed using the 'by age' regimen. As the prevalence of overweight and obesity increases in children, 12 these dosing by age measurements will become less accurate as the mean weight of children at different age ranges increases.
We are aware of the following potential limitations. First, we were unable to carry out method comparison for 60% of the study participants as they did not have scales at home, although these children did not differ from those who did in terms of, for instance, age and gender, from those included here (table 1) . Second, the parents and nurses were not blind to one another's estimates. Third, we used two methods to measure the child's weight and there may be added variation due to differences in operator. Fourth, the parents agreeing to participate in a trial may not be representative of all parents of preschool children. Finally, in a thorough investigation of the agreement between two methods, it would be advisable 
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to take replicated measurements. This would enable us to consider intermethod reliability in the context of the repeatability of each measure individually. 7 9 The results presented here show a minority of parents had home scales. It seems feasible that these parents could be asked to measure their child's weight, and calculate a dose based on this measurement, as is the case in other countries. Furthermore, it is important for clinicians/nurses/pharmacists to provide accurate advice to parents whose children do not seem to be responding to these antipyretic medications. In these cases, it is important to check the doses given, and where necessary suggest dose adjustment by using the more accurate dose for weight method if available. Countries where medicine manufacturers do not currently include dose by weight tables and dose by weight oral syringes with their products may wish to consider doing so. 
